An evaluation of how glaucoma patients use topical medications: A pilot study

Transactions of the American Ophthalmological Society

Volumn 105, Issue , 2007, Pages 29-33

  Tsai, Tony ^a   Robin, Alan L ^b,c   Smith III, Judson P ^d  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d NONE

Author keywords

[No Author keywords available]

Indexed keywords

EYE DROPS;

AGED; ARTICLE; DRUG EFFICACY; EVALUATION; FEMALE; GLAUCOMA; HUMAN; MALE; PATIENT COMPLIANCE; PATIENT EDUCATION; PILOT STUDY; PRIORITY JOURNAL; QUESTIONNAIRE;

AGED; AGED, 80 AND OVER; CONTINENTAL POPULATION GROUPS; FEMALE; GLAUCOMA; HUMANS; MALE; MIDDLE AGED; OPHTHALMIC SOLUTIONS; PATIENT COMPLIANCE; PILOT PROJECTS; QUESTIONNAIRES; TREATMENT REFUSAL; TROPICAL MEDICINE;

EID: 47749085042     PISSN: None     EISSN: 15456110     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Kass MA, Meltzer DW, Gordon M, Cooper D, Goldberg J. Compliance with topical pilocarpine treatment. Am J Ophthalmol 1986;101:515-523.
2. Kass MA, Gordon M, Meltzer DW. Can ophthalmologists correctly identify patients defaulting from pilocarpine therapy? Am J Ophthalmol 1986;101:524-530.
3. Winfield AJ, Jessiman D, Williams A, Esakowitz L. A study of the causes of non-compliance by patients prescribed eyedrops. Br J Ophthalmol 1990;74:477-480.
4. Kass MA, Hodapp E, Gordon M, Kolker AE, Goldberg I. Part I. Patient administration of eyedrops: interview. Ann Ophthalmol 1982;14:775-779.
5. Bloch S, Rosenthal AR, Friedman L, Caldarolla P. Patient compliance in glaucoma. Br J Ophthalmol 1977;61:531-534.
6. Granstrom PA. Glaucoma patients not compliant with their drug therapy: clinical and behavioural aspects. Br J Ophthalmol 1982;66:464-470.
7. Fraunfelder FT. Extraocular fluid dynamics: how best to apply topical ocular medication. Trans Am Ophthalmol Soc 1976;74:457-487.
8. Zimmerman TJ, Kooner KS, Kandarakis AS, Ziegler LP. Improving the therapeutic index of topically applied ocular drugs. Arch Ophthalmol 1984;102:551-553.
9. Geyer O, Bottone EJ, Podos SM, Schumer RA, Asbell PA. Microbial contamination of medications used to treat glaucoma. Br J Ophthalmol 1995;79:376-379.
10. Schein OD, Hibberd PL, Starck T, Baker AS, Kenyon KR. Microbial contamination of in-use ocular medications. Arch Ophthalmol 1992;110:82-85.
11. Kass MA, Hodapp E, Gordon M, Kolker AE, Goldberg I. Patient administration of eyedrops: observation. Part II. Ann Ophthalmol 1982;14:889-893.
12. Mishima S, Gasset A, Klyce SD Jr, Baum JL. Determination of tear volume and tear flow. Invest Ophthalmol 1966;5:264-276.
13. Diestelhorst M, Krieglstein GK, Lusky M, Nagasubramanian S. Clinical dose-regimen studies with latanoprost, a new ocular hypotensive PGF2 alpha analogue. Surv Ophthalmol 1997;41 Suppl 2:S77-81.
14. Novack GD, Evans R. Commercially available ocular hypotensive products: preservative concentration, stability, storage, and in-life utilization. J Glaucoma 2001;10:483-486.
15. Zimmerman TJ, Zalta AH. Facilitating patient compliance in glaucoma therapy. Surv Ophthalmol 1983;28 Suppl:252-258.